List of ADDRESS-2 publications

2023

Thomas, N.J., Walkey, H.C., Kaur, A. et al.
The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes. 
Diabetologia 66, 310–320 (2023). https://doi.org/10.1007/s00125-022-05823-1
 
 
 

2022

Grace SL, Bowden J, Walkey HC, Kaur A et al.
Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics. 
The Journal of Clinical Endocrinology & Metabolism, Volume 107, Issue 12, December 2022, Pages e4341–e4349, https://doi.org/10.1210/clinem/dgac507
 
 
 

2021

Thomas, N.J., Dennis, J.M., Sharp, S.A. et al.
DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.  
Diabetologia 64, 2258–2265 (2021). https://doi.org/10.1007/s00125-021-05513-4
 
 
 

2019

Humphreys A, Bravis V, Kaur A et al.
Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis. 
Diabetes Res Clin Pract. 2019;155:107789. doi:10.1016/j.diabres.2019.107789 
 
 
 

2018

Bravis V, Kaur A, Walkey HC on behalf of the ADDRESS-2 Management Committee, Patient Advocate Group and Investigators, et al
Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort
BMJ Open 2018;8:e020904. doi: 10.1136/bmjopen-2017-020904
 
Download
View at BMJ open
 

2017

Walkey HC, Kaur A, Bravis V, et al
Rationale and protocol for the After Diabetes Diagnosis REsearch Support System (ADDRESS): an incident and high risk type 1 diabetes UK cohort study
BMJ Open 2017;7:e013956. doi: 10.1136/bmjopen-2016-013956
 
Download
View at BMJ Open